T 0650/18 (Sclerostin neutralising antibodies/AMGEN) of 23.11.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T065018.20211123
- Date of decision
- 23 November 2021
- Case number
- T 0650/18
- Petition for review of
- -
- Application number
- 10014362.7
- IPC class
- A61K 38/17A61K 38/10C07K 14/51
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Sclerostin binding agents
- Applicant name
- Amgen, Inc.
- Opponent name
- James Poole Limited
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)
- Keywords
- Amendments - added subject-matter (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.